{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:46:12Z","timestamp":1761518772501},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4815,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1111\/j.1523-1755.2002.kid573.x","type":"journal-article","created":{"date-parts":[[2005,2,17]],"date-time":"2005-02-17T15:56:48Z","timestamp":1108655808000},"page":"1277-1284","source":"Crossref","is-referenced-by-count":58,"title":["Differential effects of 19-nor-1,25-(OH)2D2 and 1\u03b1-hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats"],"prefix":"10.1016","volume":"62","author":[{"given":"Eduardo","family":"Slatopolsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane L.","family":"Finch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0010","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.82.12.4270","article-title":"Regulation by vitamin D metabolites of messenger RNA for pre-pro-parathyroid hormone in isolated bovine parathyroid cells","volume":"82","author":"Silver","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0015","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/endo-119-6-2864","article-title":"Suppression by 1,25-(OH)2D of transcription of the parathyroid hormone gene","volume":"119","author":"Russell","year":"1985","journal-title":"Endocrinology"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0020","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/endo-117-5-2114","article-title":"1,25-Dihydroxyvitamin D3 suppresses PTH secretion from bovine parathyroid cells in tissue culture","volume":"117","author":"Cantley","year":"1985","journal-title":"Endocrinology"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02556591","article-title":"The effect of 1,25-dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells","volume":"38","author":"Chan","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0030","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0035","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114022","article-title":"Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D: A role for increased sensitivity to calcium","volume":"83","author":"Delmez","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0045","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ki.1992.404","article-title":"Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients","volume":"42","author":"Gallieni","year":"1992","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0050","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ki.1994.375","article-title":"Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol","volume":"46","author":"Cannella","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198607173150304","article-title":"Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis","volume":"315","author":"Slatopolsky","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0060","first-page":"765","article-title":"Clinical counterpoint: Vitamin D: New actions, new analogs, new therapeutic potential","volume":"13","author":"Bikle","year":"1992","journal-title":"Endocrine Rev"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0065","first-page":"156","article-title":"Selective vitamin D analogs and their therapeutic applications","volume":"14","author":"Brown","year":"1994","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0070","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1002\/jcb.240590827","article-title":"The vitamin D endocrine system: Manipulation of structure-function relationships to provide opportunities for development of new cancer chemopreventive and immunosuppressive agents","volume":"22","author":"Norman","year":"1995","journal-title":"J Cell Biochem"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0075","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.84.9.2610","article-title":"24- and 26-homo-1,25-dihydroxyviatmin D3: Preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro","volume":"84","author":"Ostrem","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0080","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0006-2952(88)90177-3","article-title":"Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo","volume":"37","author":"Binderup","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/blood.V74.1.82.82","article-title":"Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone calcium mobilization","volume":"74","author":"Zhou","year":"1989","journal-title":"Blood"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0090","first-page":"1143","article-title":"Comparison of the inhibitions of proliferation of normal and psoriatic fibroblasts by 1\u03b1,25-dihydoxyvitamin D3 and synthetic analogues of vitamin D3 with an oxygen atom in their side chain","volume":"19","author":"Morimoto","year":"1989","journal-title":"Biochem Int"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0955-2863(93)90020-W","article-title":"An evaluation of 1,25-dihydroxyvitamin D3 analogues on the proliferation and differentiation of cultured human keratinocytes, calcium metabolism, and the differentiation of human HL-60 cells","volume":"4","author":"Chen","year":"1993","journal-title":"J Nutr Biochem"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0100","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1210\/endo-129-2-832","article-title":"A novel vitamin D3 analog, 22-oxa-1,25-dihydoxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia","volume":"129","author":"Abe","year":"1991","journal-title":"Endocrinology"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00001813-199110000-00007","article-title":"Antitumor effect of 22-oxa-1\u03b1,25-dihydoxyvitamin D3, a potent angiogenesis inhibitor, on rat mammary tumors induced by 7,12-dimethylbenz[a]-anthracene","volume":"2","author":"Oikawa","year":"1991","journal-title":"Anticancer Drugs"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0006-2952(92)90405-8","article-title":"Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro","volume":"44","author":"Colston","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0115","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/endo-124-5-2645","article-title":"A synthetic analogue of vitamin D3, 22-oxa-1\u03b1,25-dihydoxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice","volume":"124","author":"Abe","year":"1989","journal-title":"Endocrinology"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0120","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A new analog of Calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"Am J Kid Dis"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(97)90571-0","article-title":"A new analogue of 1,25-(OH)2D3, 19-nor-1,25-(OH)2D2, suppresses PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content","volume":"30","author":"Takahashi","year":"1997","journal-title":"Am J Kid Dis"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.1997.39","article-title":"Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism","volume":"51","author":"Tan","year":"1997","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0135","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/ajkd.2001.22077","article-title":"Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1\u03b1-hydrovitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison","volume":"37","author":"Maung","year":"2001","journal-title":"Am J Kid Dis"},{"issue":"Suppl 73","key":"10.1111\/j.1523-1755.2002.kid573.x_bb0140","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1046\/j.1523-1755.1999.07314.x","article-title":"Osteodystrophy in the millennium","volume":"56","author":"Ritz","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0145","first-page":"32","article-title":"Renal osteodystrophy: Management of hyperphosphatemia","volume":"15","author":"Drueke","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s004670000341","article-title":"Pathophysiology of renal osteodystrophy","volume":"14","author":"Hruska","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-nor-1-\u03b1-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mlc.2002.122819","article-title":"The relative potencies of 1,25(OH)2D3 and 19-nor-1,25(OH)2D2 on intestinal calcium and phosphorus absorption","volume":"139","author":"Brown","year":"2002","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0165","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V105980","article-title":"Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone","volume":"10","author":"Finch","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0170","first-page":"E402","article-title":"Biological activity of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3","volume":"254","author":"DeLuca","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0003-9861(89)90162-8","article-title":"Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and epimer","volume":"273","author":"Reinhardt","year":"1989","journal-title":"Arch Biochem Biophys"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0180","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1681\/ASN.V11101857","article-title":"1,25-Dihydroxy-19-nor-vitamin D2, a vitamin D analog with reduced bone resorbing activity in vitro","volume":"11","author":"Holiday","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0190","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclasto-genesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0195","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1084\/jem.188.5.997","article-title":"TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts","volume":"188","author":"Fuller","year":"1998","journal-title":"J Exp Med"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0200","series-title":"Vitamin D","first-page":"13","article-title":"Metabolism of vitamins D2 and D3,","author":"Horst","year":"1997"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0205","first-page":"1358","article-title":"Acute vitamin D3 toxicosis in horses: Case reports and experimental studies of the comparative toxicity of vitamins D2 and D3","volume":"182","author":"Harrington","year":"1989","journal-title":"J Am Vet Med Assoc"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0210","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3181\/00379727-178-42028","article-title":"1-\u03b1-Hydroxyvitamin D2 is less toxic than 1-\u03b1-hydroxyvitamin D3 in the rat","volume":"178","author":"Sj\u00f6den","year":"1985","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0215","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/bi00454a035","article-title":"1-\u03b1-Hydroxylation of 24-hydroxyvitamin D2 represents a minor physiological pathway for the activation of vitamin D2 in mammals","volume":"29","author":"Horst","year":"1990","journal-title":"Biochemistry"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0220","first-page":"2156","article-title":"Unique 24-hydroxylated metabolites represent a significant pathway of metabolism of vitamin D2 in humans: 24-hydroxyvitamin D2 and 1,24-dihydroxyvitamin D2 detectable in human serum","volume":"83","author":"Mawer","year":"1998","journal-title":"J Clin Endocrin Metabol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0225","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1074\/jbc.270.18.10551","article-title":"Distinct conformational changes induced by 20-epi analogues of 1\u03b1,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor","volume":"270","author":"Peleg","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0230","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1128\/MCB.19.2.1049","article-title":"Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog","volume":"19","author":"Takeyama","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0235","doi-asserted-by":"crossref","first-page":"16838","DOI":"10.1074\/jbc.274.24.16838","article-title":"20-Epi analogues of 1\u03b1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D receptor","volume":"274","author":"Yang","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0240","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1124\/mol.55.6.1077","article-title":"Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs","volume":"55","author":"Quack","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0245","series-title":"USRDS 1999 Annual Data Report","author":"US Renal Data System","year":"1999"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1073-4449(97)70028-1","article-title":"Cardiac disease in chronic uremia","volume":"4","author":"Bloembergen","year":"1997","journal-title":"Epidemiol Adv Ren Replac Ther"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0255","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1378\/chest.105.2.383","article-title":"Mitral valve calcification as an index of left ventricular dysfunction in patients with end stage renal disease on peritoneal dialysis","volume":"105","author":"Huting","year":"1994","journal-title":"Chest"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0260","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/ndt\/13.8.2037","article-title":"Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism","volume":"13","author":"Ribeiro","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1525-139X.1999.99041.x","article-title":"New therapies raise new issues for lowering parathyroid hormone levels in uremic patients","volume":"12","author":"Andress","year":"1999","journal-title":"Semin Dial"},{"key":"10.1111\/j.1523-1755.2002.kid573.x_bb0270","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","article-title":"Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management","volume":"6","author":"Block","year":"2000","journal-title":"Am J Kid Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815486697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815486697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:39:18Z","timestamp":1625459958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815486697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0085253815486697"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2002.kid573.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}